Drug-coated balloon treatment for left main coronary artery blockages
Part of Heart & circulation clinical trials.
This study tests whether using a drug-coated balloon alongside a stent improves outcomes for people with a blockage in the left main coronary artery, the main artery supplying the heart. It compares this approach to standard stenting, aiming to reduce re-blockage risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a significant narrowing in the left main coronary artery where it branches into two other arteries.
- The narrowed artery diameter is 6 mm or less, and the two branch arteries are wider than 2.75 mm.
- You have not had a previous procedure (stent or balloon) on this specific left main bifurcation.
- You are not currently having a heart attack with ST elevation (STEMI) and do not have cardiogenic shock.
- Your heart pumping ability (ejection fraction) is 35% or higher.
- You are able to take blood-thinning medicines (dual antiplatelet therapy) for at least 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a new way to treat blockages in the left main coronary artery using a drug-coated stent. It aims to find out if a careful approach with a single stent and temporary side-branch support works well for people with heart disease.
This trial studies whether a drug-coated balloon can treat certain coronary artery narrowings in adults with chronic (long-term) coronary disease. It may help prevent re-narrowing after the procedure for people whose tests show the blockage is significant and needs treatment.
This trial tests a special balloon coated with a drug (sirolimus) to treat blockages in small heart arteries. If the balloon is successful, it may help keep the artery open without needing a permanent stent.
This study compares two kinds of drug-coated balloons used during angioplasty to open narrowed heart arteries in people with acute coronary syndrome. Both balloons slowly release medicine to help keep the artery open, and the trial aims to see if one works better than the other.
This trial compares two ways to treat a coronary artery blockage at a fork (bifurcation): one uses a standard stent, the other uses a special balloon that releases medication to keep the artery open. It aims to find which approach is safer and more effective for patients with this specific type of blockage.
This study is testing a special balloon that releases a drug (sirolimus) to treat fatty plaques in heart arteries that are not yet blocking blood flow. The hope is that this treatment can stabilize or even shrink these plaques, reducing future risk of heart attacks. If you have recently had a heart attack and have other non-obstructive plaques, this trial might offer a new approach.
Hear when a new Left Main Coronary Artery Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.